NovaBay Pharmaceuticals
Stock Forecast, Prediction & Price Target
NovaBay Pharmaceuticals Financial Estimates
NovaBay Pharmaceuticals Revenue Estimates
NovaBay Pharmaceuticals EBITDA Estimates
NovaBay Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $8.42M N/A | $14.40M 71.04% | $14.72M 2.23% | Avg: $18.72M Low: $17M High: $20.44M avg. 27.12% | |||
Net Income
% change YoY
| $-6.55M N/A | $-16.26M -147.97% | $-9.64M 40.73% | Avg: $-395K Low: $-1.63M High: $-1.31M avg. 95.90% | |||
EBITDA
% change YoY
| $-13.35M N/A | $-4.54M 65.97% | $-4.8M -5.61% | Avg: $-10.32M Low: $-11.27M High: $-9.37M avg. -115.16% | |||
EPS
% change YoY
| -$5.26 N/A | -$10.1 -92.01% | -$138.65 -1272.77% | Avg: -$0.35 Low: -$0.39 High: -$0.31 avg. 99.74% | |||
Operating Expenses
% change YoY
| $14.50M N/A | $15.46M 6.57% | $12.89M -16.57% | Avg: $26.21M Low: $23.80M High: $28.62M avg. 103.24% | |||
FAQ
What is NovaBay Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 95.90% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -1.63M, average is -395K and high is -1.31M.
What is NovaBay Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 27.12% in 2025-2025.
We have gathered data from 2 analysts. Their low revenue estimate is $17M, average is $18.72M and high is $20.44M.
What is NovaBay Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 99.74% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.39, average is -$0.35 and high is $-0.31.